BioStock: Curasight applies for clinical trial of uTREAT for brain cancer
19 juni, 08:40
19 juni, 08:40
Danish biotech company Curasight has submitted an application to the EMA for clinical trial authorisation to the EMA for a phase I study of uTREAT in patients with glioblastoma. The first patient is expected to receive treatment in the second half of 2025.
Read the full article at biostock.se:
https://biostock.se/en/2025/06/curasight-klinisk-provning-utreat-hjarncancer/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/
Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!
About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.
19 juni, 08:40
Danish biotech company Curasight has submitted an application to the EMA for clinical trial authorisation to the EMA for a phase I study of uTREAT in patients with glioblastoma. The first patient is expected to receive treatment in the second half of 2025.
Read the full article at biostock.se:
https://biostock.se/en/2025/06/curasight-klinisk-provning-utreat-hjarncancer/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/
Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!
About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.
Fondernas placeringar
Placeras aktieanalyser
Aktieråd
Fondernas placeringar
Placeras aktieanalyser
Aktieråd
1 DAG %
Senast
SSAB
19 juni, 17:38
Surt på Stockholmsbörsen – skogsbolag mot strömmen
OMX Stockholm 30
1 DAG %
Senast
2 447,13